PMGC HOLDINGS INC. Payments to Acquire Investments
PMGC HOLDINGS INC. (ELAB) reported Payments to Acquire Investments of $2.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-08-14
- PMGC HOLDINGS INC. payments to acquire investments for the quarter ending 2026-06-30 was $1.44M, a 154.02% increase year-over-year.
- PMGC HOLDINGS INC. payments to acquire investments for the quarter ending 2026-03-31 was $1.44M, a 233.79% increase year-over-year.
- PMGC HOLDINGS INC. payments to acquire investments for the quarter ending 2025-12-31 was $224.99K.
- PMGC HOLDINGS INC. payments to acquire investments for the quarter ending 2025-09-30 was $568.96K.
- PMGC HOLDINGS INC. payments to acquire investments for fiscal 2025 was $1.79M, a 1186.30% increase from fiscal 2024.
- PMGC HOLDINGS INC. payments to acquire investments for fiscal 2024 was $139.08K.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.87M 10-Q · filed 2026-08-14 | $3.10M derived: sum of 3 quarters · filed 2026-08-14 | $3.66M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $1.44M 10-Q · filed 2026-05-15 | $1.66M derived: sum of 2 quarters · filed 2026-05-15 | $2.23M derived: sum of 3 quarters · filed 2026-05-15 | $2.79M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $224.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $793.94K derived: sum of 2 quarters · filed 2026-03-30 | $1.36M derived: sum of 3 quarters · filed 2026-08-14 | $1.79M 10-K · filed 2026-03-30 |
| 2025-09-30 | $568.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.13M derived: sum of 2 quarters · filed 2026-08-14 | $1.56M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $565.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $995.10K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $430.02K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $139.08K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |